Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review.

Naik RP, Smith-Whitley K, Hassell KL, Umeh NI, de Montalembert M, Sahota P, Haywood C Jr, Jenkins J, Lloyd-Puryear MA, Joiner CH, Bonham VL, Kato GJ.

Ann Intern Med. 2018 Nov 6;169(9):619-627. doi: 10.7326/M18-1161. Epub 2018 Oct 30.

2.

Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades.

Therrell BL Jr, Lloyd-Puryear MA, Eckman JR, Mann MY.

Semin Perinatol. 2015 Apr;39(3):238-51. doi: 10.1053/j.semperi.2015.03.008. Review.

PMID:
25979783
3.

Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning.

Therrell BL Jr, Lloyd-Puryear MA, Camp KM, Mann MY.

Mol Genet Metab. 2014 Sep-Oct;113(1-2):14-26. doi: 10.1016/j.ymgme.2014.07.009. Epub 2014 Jul 16. Review.

4.

Phenylketonuria Scientific Review Conference: state of the science and future research needs.

Camp KM, Parisi MA, Acosta PB, Berry GT, Bilder DA, Blau N, Bodamer OA, Brosco JP, Brown CS, Burlina AB, Burton BK, Chang CS, Coates PM, Cunningham AC, Dobrowolski SF, Ferguson JH, Franklin TD, Frazier DM, Grange DK, Greene CL, Groft SC, Harding CO, Howell RR, Huntington KL, Hyatt-Knorr HD, Jevaji IP, Levy HL, Lichter-Konecki U, Lindegren ML, Lloyd-Puryear MA, Matalon K, MacDonald A, McPheeters ML, Mitchell JJ, Mofidi S, Moseley KD, Mueller CM, Mulberg AE, Nerurkar LS, Ogata BN, Pariser AR, Prasad S, Pridjian G, Rasmussen SA, Reddy UM, Rohr FJ, Singh RH, Sirrs SM, Stremer SE, Tagle DA, Thompson SM, Urv TK, Utz JR, van Spronsen F, Vockley J, Waisbren SE, Weglicki LS, White DA, Whitley CB, Wilfond BS, Yannicelli S, Young JM.

Mol Genet Metab. 2014 Jun;112(2):87-122. doi: 10.1016/j.ymgme.2014.02.013. Epub 2014 Mar 6.

PMID:
24667081
5.

Expanding research to provide an evidence base for nutritional interventions for the management of inborn errors of metabolism.

Camp KM, Lloyd-Puryear MA, Yao L, Groft SC, Parisi MA, Mulberg A, Gopal-Srivastava R, Cederbaum S, Enns GM, Ershow AG, Frazier DM, Gohagan J, Harding C, Howell RR, Regan K, Stacpoole PW, Venditti C, Vockley J, Watson M, Coates PM.

Mol Genet Metab. 2013 Aug;109(4):319-28. doi: 10.1016/j.ymgme.2013.05.008. Epub 2013 May 23.

6.

Insurance coverage of medical foods for treatment of inherited metabolic disorders.

Berry SA, Kenney MK, Harris KB, Singh RH, Cameron CA, Kraszewski JN, Levy-Fisch J, Shuger JF, Greene CL, Lloyd-Puryear MA, Boyle CA.

Genet Med. 2013 Dec;15(12):978-82. doi: 10.1038/gim.2013.46. Epub 2013 Apr 18.

7.

Improving newborn screening follow-up in pediatric practices: quality improvement innovation network.

Hinton CF, Neuspiel DR, Gubernick RS, Geleske T, Healy J, Kemper AR, Lloyd-Puryear MA, Saul RA, Thompson BH, Kaye CI.

Pediatrics. 2012 Sep;130(3):e669-75. doi: 10.1542/peds.2011-2920. Epub 2012 Aug 6.

PMID:
22869832
8.

Nutritional treatment for inborn errors of metabolism: indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example.

Camp KM, Lloyd-Puryear MA, Huntington KL.

Mol Genet Metab. 2012 Sep;107(1-2):3-9. doi: 10.1016/j.ymgme.2012.07.005. Epub 2012 Jul 16. Review.

9.

Public health implications of sickle cell trait: a report of the CDC meeting.

Grant AM, Parker CS, Jordan LB, Hulihan MM, Creary MS, Lloyd-Puryear MA, Goldsmith JC, Atrash HK.

Am J Prev Med. 2011 Dec;41(6 Suppl 4):S435-9. doi: 10.1016/j.amepre.2011.09.012.

PMID:
22099370
10.

Sickle cell disease: the need for a public health agenda.

Yusuf HR, Lloyd-Puryear MA, Grant AM, Parker CS, Creary MS, Atrash HK.

Am J Prev Med. 2011 Dec;41(6 Suppl 4):S376-83. doi: 10.1016/j.amepre.2011.09.007.

PMID:
22099361
11.

A public health framework for rare blood disorders.

Grosse SD, James AH, Lloyd-Puryear MA, Atrash HK.

Am J Prev Med. 2011 Dec;41(6 Suppl 4):S319-23. doi: 10.1016/j.amepre.2011.09.010. No abstract available.

PMID:
22099353
12.

Standardizing newborn screening results for health information exchange.

Abhyankar S, Lloyd-Puryear MA, Goodwin R, Copeland S, Eichwald J, Therrell BL, Zuckerman A, Downing G, McDonald CJ.

AMIA Annu Symp Proc. 2010 Nov 13;2010:1-5.

13.

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project.

McHugh D, Cameron CA, Abdenur JE, Abdulrahman M, Adair O, Al Nuaimi SA, Åhlman H, Allen JJ, Antonozzi I, Archer S, Au S, Auray-Blais C, Baker M, Bamforth F, Beckmann K, Pino GB, Berberich SL, Binard R, Boemer F, Bonham J, Breen NN, Bryant SC, Caggana M, Caldwell SG, Camilot M, Campbell C, Carducci C, Bryant SC, Caggana M, Caldwell SG, Camilot M, Campbell C, Carducci C, Cariappa R, Carlisle C, Caruso U, Cassanello M, Castilla AM, Ramos DE, Chakraborty P, Chandrasekar R, Ramos AC, Cheillan D, Chien YH, Childs TA, Chrastina P, Sica YC, de Juan JA, Colandre ME, Espinoza VC, Corso G, Currier R, Cyr D, Czuczy N, D'Apolito O, Davis T, de Sain-Van der Velden MG, Delgado Pecellin C, Di Gangi IM, Di Stefano CM, Dotsikas Y, Downing M, Downs SM, Dy B, Dymerski M, Rueda I, Elvers B, Eaton R, Eckerd BM, El Mougy F, Eroh S, Espada M, Evans C, Fawbush S, Fijolek KF, Fisher L, Franzson L, Frazier DM, Garcia LR, Bermejo MS, Gavrilov D, Gerace R, Giordano G, Irazabal YG, Greed LC, Grier R, Grycki E, Gu X, Gulamali-Majid F, Hagar AF, Han L, Hannon WH, Haslip C, Hassan FA, He M, Hietala A, Himstedt L, Hoffman GL, Hoffman W, Hoggatt P, Hopkins PV, Hougaard DM, Hughes K, Hunt PR, Hwu WL, Hynes J, Ibarra-González I, Ingham CA, Ivanova M, Jacox WB, John C, Johnson JP, Jónsson JJ, Karg E, Kasper D, Klopper B, Katakouzinos D, Khneisser I, Knoll D, Kobayashi H, Koneski R, Kozich V, Kouapei R, Kohlmueller D, Kremensky I, la Marca G, Lavochkin M, Lee SY, Lehotay DC, Lemes A, Lepage J, Lesko B, Lewis B, Lim C, Linard S, Lindner M, Lloyd-Puryear MA, Lorey F, Loukas YL, Luedtke J, Maffitt N, Magee JF, Manning A, Manos S, Marie S, Hadachi SM, Marquardt G, Martin SJ, Matern D, Mayfield Gibson SK, Mayne P, McCallister TD, McCann M, McClure J, McGill JJ, McKeever CD, McNeilly B, Morrissey MA, Moutsatsou P, Mulcahy EA, Nikoloudis D, Norgaard-Pedersen B, Oglesbee D, Oltarzewski M, Ombrone D, Ojodu J, Papakonstantinou V, Reoyo SP, Park HD, Pasquali M, Pasquini E, Patel P, Pass KA, Peterson C, Pettersen RD, Pitt JJ, Poh S, Pollak A, Porter C, Poston PA, Price RW, Queijo C, Quesada J, Randell E, Ranieri E, Raymond K, Reddic JE, Reuben A, Ricciardi C, Rinaldo P, Rivera JD, Roberts A, Rocha H, Roche G, Greenberg CR, Mellado JM, Juan-Fita MJ, Ruiz C, Ruoppolo M, Rutledge SL, Ryu E, Saban C, Sahai I, García-Blanco MI, Santiago-Borrero P, Schenone A, Schoos R, Schweitzer B, Scott P, Seashore MR, Seeterlin MA, Sesser DE, Sevier DW, Shone SM, Sinclair G, Skrinska VA, Stanley EL, Strovel ET, Jones AL, Sunny S, Takats Z, Tanyalcin T, Teofoli F, Thompson JR, Tomashitis K, Domingos MT, Torres J, Torres R, Tortorelli S, Turi S, Turner K, Tzanakos N, Valiente AG, Vallance H, Vela-Amieva M, Vilarinho L, von Döbeln U, Vincent MF, Vorster BC, Watson MS, Webster D, Weiss S, Wilcken B, Wiley V, Williams SK, Willis SA, Woontner M, Wright K, Yahyaoui R, Yamaguchi S, Yssel M, Zakowicz WM.

Genet Med. 2011 Mar;13(3):230-54. doi: 10.1097/GIM.0b013e31820d5e67.

PMID:
21325949
14.

Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative.

Auchus RJ, Witchel SF, Leight KR, Aisenberg J, Azziz R, Bachega TA, Baker LA, Baratz AB, Baskin LS, Berenbaum SA, Breault DT, Cerame BI, Conway GS, Eugster EA, Fracassa S, Gearhart JP, Geffner ME, Harris KB, Hurwitz RS, Katz AL, Kalro BN, Lee PA, Alger Lin G, Loechner KJ, Marshall I, Merke DP, Migeon CJ, Miller WL, Nenadovich TL, Oberfield SE, Pass KA, Poppas DP, Lloyd-Puryear MA, Quigley CA, Riepe FG, Rink RC, Rivkees SA, Sandberg DE, Schaeffer TL, Schlussel RN, Schneck FX, Seely EW, Snyder D, Speiser PW, Therrell BL, Vanryzin C, Vogiatzi MG, Wajnrajch MP, White PC, Zuckerman AE.

Int J Pediatr Endocrinol. 2010;2010:275213. doi: 10.1155/2010/275213. Epub 2011 Jan 10.

15.

Clinical report—health supervision for children with Prader-Willi syndrome.

McCandless SE; Committee on Genetics.

Pediatrics. 2011 Jan;127(1):195-204. doi: 10.1542/peds.2010-2820. Epub 2010 Dec 27.

PMID:
21187304
16.

Long-term follow-up of newborn screening patients.

Berry SA, Lloyd-Puryear MA, Watson MS.

Genet Med. 2010 Dec;12(12 Suppl):S267-8. doi: 10.1097/GIM.0b013e3181fea476.

PMID:
21150374
17.

Long-term follow-up in newborn screening: A systems approach for improving health outcomes.

Lloyd-Puryear MA, Brower A.

Genet Med. 2010 Dec;12(12 Suppl):S256-60. doi: 10.1097/GIM.0b013e3181fe5d9c.

PMID:
21150372
18.

Future research directions to identify causes of the increasing incidence rate of congenital hypothyroidism in the United States.

Shapira SK, Lloyd-Puryear MA, Boyle C.

Pediatrics. 2010 May;125 Suppl 2:S64-8. doi: 10.1542/peds.2009-1975G.

PMID:
20435719
19.

Medical foods: inborn errors of metabolism and the reimbursement dilemma.

Weaver MA, Johnson A, Singh RH, Wilcox WR, Lloyd-Puryear MA, Watson MS.

Genet Med. 2010 Jun;12(6):364-9. doi: 10.1097/GIM.0b013e3181deb2f0. Erratum in: Genet Med. 2013 Feb;15(2):161.

PMID:
20445457
20.

Enhancing the quality and efficiency of newborn screening programs through the use of health information technology.

Downing GJ, Zuckerman AE, Coon C, Lloyd-Puryear MA.

Semin Perinatol. 2010 Apr;34(2):156-62. doi: 10.1053/j.semperi.2009.12.005.

PMID:
20207265

Supplemental Content

Loading ...
Support Center